A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

President Global Supply Chain, GSK said. “We’re grateful for the support of local and state officials, who made this project possible, and we are excited to expand upon the important work ...

GSK has pledged to 100% use of renewable across the company by 2025, and an 80% reduction in carbon emissions by 2030 en route to net zero across all its supply chain – including purchased goods ...

GSK, meanwhile, has also completed another ... but proved particularly tough on the supply chains relied on to support public health. Discover how AI is transforming the pharma commercial strategy.

We will deliver our fully reinvigorated portfolio to market efficiently and maximise the considerable commercial potential, ...

GSK is delivering consistent financial performance ... as we plan to make further investments to drive future supply chain efficiencies, with additional charges of around GBP100 million.

Luxury fashion and lifestyle group Kering, pharma giant GSK and building materials producer Holcim have become the first ...

LONDON — GSK’s once-booming vaccines business met new challenges in the third quarter, as the company lowered sales forecasts for vaccines for the year. Notably, quarterly sales of the ...

chain structures, segmentation and sub-segments so on. It highlights various modifications held in the market to improve the market growth. The market report reviews the effect of demand, supply, ...

(Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, ...

A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster ...